value

With the growing use of regulatory tools such as conditional approvals and breakthrough designations, the traditional bottleneck of regulatory approval is today seen as far less problematic than it was previously. However, the early assessment of new products is also increasingly accompanied by smaller datasets that are often extrapolated for outcomes and survival. This creates … Read more